Provided by Tiger Fintech (Singapore) Pte. Ltd.

ATI Inc

43.00
-5.8800-12.03%
Post-market: 43.450.4500+1.05%19:19 EDT
Volume:3.38M
Turnover:147.71M
Market Cap:6.11B
PE:16.87
High:47.36
Open:46.59
Low:42.45
Close:48.88
Loading ...

Allegheny Technologies (ATI) Q3 Earnings and Revenues Lag Estimates

Zacks
·
29 Oct 2024

ATI Q3 Adjusted Earnings Fall, Sales Rise; 2024 EPS Guidance Lowered

MT Newswires Live
·
29 Oct 2024

BRIEF-Ati Announces Third Quarter 2024 Results

Reuters
·
29 Oct 2024

ATI Lowers 2024 Guidance: Now Sees Adj. EPS Of $2.24-$2.30 (Prior $2.40-$2.60) Vs. $2.45 Est.; Sees Adjusted EBITDA Of $700M-$710M (Prior $720M - $750M)

Benzinga
·
29 Oct 2024

Allegheny Technologies: Q3 Earnings Snapshot

Associated Press Finance
·
29 Oct 2024

Stock Track | ATI Stock Plunges After Disappointing Q3 Earnings Miss

Stock Track
·
29 Oct 2024

ATI Shares Down 7.5% Premarket After FY Profit Forecast Below Estimates

THOMSON REUTERS
·
29 Oct 2024

ATI Q3 2024 Adj. EPS $0.60 Misses $0.66 Estimate, Sales $1.051B Miss $1.124B Estimate

Benzinga
·
29 Oct 2024

ATI - Expect to Continue to See Uncertainty With Our Most Critical Customers Through Remainder of 2024 and First Part of 2025

THOMSON REUTERS
·
29 Oct 2024

ATI - Outlook 2024 Adj EPS $2.24 - $2.30 VS Ibes Estimate $2.45

THOMSON REUTERS
·
29 Oct 2024

ATI Q3 Revenue USD 1,051.2 Million VS. Ibes Estimate USD 1,124 Million

THOMSON REUTERS
·
29 Oct 2024

ATI Announces Third Quarter 2024 Results

PR Newswire
·
29 Oct 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
28 Oct 2024

ATI Cut to Sector Weight From Overweight by Keybanc

Dow Jones
·
24 Oct 2024

KeyBanc Downgrades ATI to Sector Weight From Overweight

MT Newswires Live
·
24 Oct 2024

ATI downgraded to Sector Weight from Overweight at KeyBanc

TIPRANKS
·
24 Oct 2024

Allegheny Technologies (ATI) Stock Moves -0.44%: What You Should Know

Zacks
·
24 Oct 2024

Allegheny Technologies (ATI) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
22 Oct 2024

ATI Physical Therapy to Announce Third Quarter 2024 Financial Results

PR Newswire
·
22 Oct 2024

BRIEF-Appili Therapeutics Presents Update On ATI-1701 Biodefense Vaccine Candidate At IDWeek™ 2024

Reuters
·
17 Oct 2024